Summary

Results from the Rapid Identification of Treatment Effectiveness in Major Depression [BRITE-MD] study suggest that the use of frontal quantitative EEG could be used as a biomarker to predict treatment outcome with the antidepressant escitalopram.

  • mood disorders clinical trials
  • psychopharmacology
View Full Text